Table 1. Baseline demographics of patients with gastrointestinal schwannomas.
| N | % | ||
| Age | Years | Mean (SD) = 59.2 (12.6) | |
| Age group | 18–35 | 1 | 2.3 |
| 36–50 | 8 | 18.2 | |
| 51–65 | 21 | 47.7 | |
| > 65 | 14 | 31.8 | |
| Race | White | 37 | 84.1 |
| Black | 3 | 6.8 | |
| Other | 4 | 9.1 | |
| Gender | Female | 28 | 63.6 |
| Male | 16 | 36.4 | |
| BMI | 29.49 | 7.60 | |
| Smoking | Current | 14 | 31.8 |
| Former | 11 | 25.0 | |
| Never | 19 | 43.2 | |
| Pack yeasr of smoking | 12.65 | 20.29 | |
| Comorbidities | Alcohol | 11 | 25.0 |
| CKD | 5 | 11.4 | |
| ESRD | 0 | 0 | |
| Cirrhosis | 0 | 0 | |
| COPD | 5 | 11.4 | |
| CHF | 1 | 2.3 | |
| Cancer | 10 | 22.7 | |
| Type of cancer | Breast | 1 | |
| Colon | 1 | ||
| Colon, GIST | 1 | ||
| Gastric cancer | 1 | ||
| GIST | 1 | ||
| Lung | 1 | ||
| NHL | 1 | ||
| Pancreatic cancer | 1 | ||
| Renal | 2 | ||
| Family history of cancer | 4 | 9.1 % | |
| Colon (2) | |||
| Pancreas (1) | |||
| Prostate (1) | |||
| IBD | Crohnʼs ds | 4 | 9.1 |
| Medications | PPIs | 21 | 47.7 |
| Steroids | 4 | 9.1 | |
| Immune suppression | 4 | 9.1 |
SD, standard deviation; BMI, body mass index; CKD, chronic kidney disease; ESRD, end-stage renal disease; COPD, chronic obstructive pulmonary disease; CHF, chronic heart failure; GIST, gastrointestinal stromal tumor; NHL, non-Hodgkin lymphoma; IBD, inflammatory bowel disease.